MedTrace Logo

the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris

NCT00419848 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2008-01-29

No results posted yet for this study

Summary

a comparison of efficacy and adverse side effects occurrence of Doxycycline and Azithromycin in the management of moderate acne vulgaris

Conditions

Interventions

DRUG

Doxycycline

Cap 100mg- 100mg/daily

DRUG

Azithromycin

Azithromycin: Cap 250 mg- 500 mg single dose/daily - 3 times per week

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Principal Investigators

  • Parviz Toossi, M.D. · Skin Research Center

  • Hamideh Moravvej, M.D. · Skin Research Center

  • Akbar Mousazadeh halim, M.D. · Skin Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-01-31
Completion
2008-02-29

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00419848 on ClinicalTrials.gov